OnDemand
SGLT2 Inhibitors: The new wonder drugs in cardiology?
  • Detail & Program Access
  • Overview & Objectives
  • Credit Eligibility
  • Faculty
  • Agenda
  • Program Materials
  • Funding Support
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES and a PROGRAM WORKSHEET. View the Program Materials tab for more information.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

program advertising tile
CLICK HERE TO VIEW THE VIDEO

Program Access and Details:

Program Length:
90 minutes

Resources:
DOWNLOADABLE SLIDES and a PROGRAM WORKSHEET. View the Program Materials tab for more information.

Target Audience:
Family physicians, cardiovascular specialists, allied health professionals

program advertising tile

This program provides a case-based discussion on SGLT2 inhibition for glycemic control and newer indications such as heart failure prevention, treatment, and management of chronic kidney disease.

This program is NOT accredited.

Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio. 

David Cherney
MD, CM, PhD, FRCPC
Toronto, ON
Milan Gupta
MD, FRCPC, FCCS, CPC(HC)
Brampton, ON
Robyn Houlden
MD, FRCPC
Kingston, ON
Peter Lin
MD, CCFP
Toronto, ON
Program Chapter
Presenter
Opening Comments
Milan Gupta
Overview of class benefits in patients with diabetes at high CV risk
Robyn Houlden
Interplay between diabetes, heart failure, and kidney disease
David Cherney
Latest clinical trials results with SGLT2 inhibitors in heart failure
Milan Gupta
Latest clinical trials results with SGLT2 inhibitors in CKD
David Cherney
Discussion
Peter Lin

Download program handout/worksheet: 

Participant Handout

Program slides:

This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization.  A PDF copy of the slides from this program are available for CCRN members from the CCRN website. Click the link below to be directed to the Resource Library.

Access CCRN Member Resource Library.

This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from AstraZeneca and Janssen

 

© 2020-2021 MDLearn, All Rights are Reserved